Bone Marrow Adipocytes: A Link between Obesity and Bone Cancer.
Bone Marrow Adipocytes: A Link between Obesity and Bone Cancer.
复制标题
骨髓脂肪细胞:肥胖与骨癌之间的联系。
DOI:
10.3390/cancers13030364
复制
发表时间:
2021-01-20
期刊:
影响因子:
5.2
通讯作者:
Rosen CJ
中科院分区:
文献类型:
--
作者:
Reagan MR;Fairfield H;Rosen CJ
This review discusses the important newly-established roles for bone marrow adipose tissue in cancer progression and highlights the research demonstrating great promise for clinically targeting the cells in oncology. Bone marrow adipose tissue expands during aging and in obesity. It primarily comprises bone marrow adipocytes (also known as fat cells) and can also contain other cells, such as pre-adipocytes, fibroblasts, macrophages, other immune cells, and endothelial cells. Bone marrow adipocytes are scattered throughout the hematopoietic or “red” marrow, or are densely packed in the marrow cavity, creating “yellow” marrow. Bone marrow biologists are interrogating many questions to understand the nature of bone marrow adipocytes, including how aging and obesity affect these cells; their origins, functions, and endocrine roles; and whether they can be targeted to treat osteoporosis. In parallel, and often in concert, cancer researchers are delineating the role of bone marrow adipocytes in oncology and their potential translational significance for future therapeutics. Cancers that grow in the bone marrow are for most patients scary, painful, and incurable. These cancers are especially hard to treat due to the supportive microenvironment provided by the bone marrow niche in which they reside. New therapies designed to target tumor cells have extended the life expectancy for these patients, but better therapies are needed and new ideas for how to target these cancers are crucial. This need has led researchers to interrogate whether bone marrow adipocytes (BMAds), which increase in number and size during aging and in obesity, contribute to cancer initiation or progression within the bone marrow. Across the globe, the consensus in the field is a unified “yes”. However, how to target these adipocytes or the factors they produce and how BMAds interact with different tumor cells are open research questions. Herein, we review this research field, with the goal of accelerating research in the network of laboratories working in this area and attracting bright scientists with new perspectives and ideas to the field in order to bring about better therapies for patients with bone cancers.
登录
查看更多内容
影响因子:
7.8
作者:
Almeida M;Kim HN;Han L;Zhou D;Thostenson J;Porter RM;Ambrogini E;Manolagas SC;Jilka RL
通讯作者:
Jilka RL
影响因子:
4.1
作者:
Fairfield H;Falank C;Farrell M;Vary C;Boucher JM;Driscoll H;Liaw L;Rosen CJ;Reagan MR
通讯作者:
Reagan MR
影响因子:
6
作者:
Clark, Robert;Krishnan, Venkatesh;Rinker-Schaeffert, Carrie
通讯作者:
Rinker-Schaeffert, Carrie
影响因子:
--
作者:
Diedrich JD;Rajagurubandara E;Herroon MK;Mahapatra G;Hüttemann M;Podgorski I
通讯作者:
Podgorski I
DOI:
10.1002/jbmr.4170
发表时间:
2021-01
期刊:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
影响因子:
--
作者:
Farrell M;Fairfield H;Costa S;D'Amico A;Falank C;Brooks DJ;Reagan MR
通讯作者:
Reagan MR